Podchaser Logo
Home
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Released Tuesday, 19th July 2022
Good episode? Give it some love!
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Tuesday, 19th July 2022
Good episode? Give it some love!
Rate Episode

Unlock Episode Insights with

Podchaser Logo PRO

Reach • Demographics • Contacts • More

Pro Features

Audience & Reach for Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

See a breakdown of Audience & Reach for Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Unlock Episode Audience & Reach with Podchaser Pro

Brand Safety for Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

See Brand Safety for Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Unlock Episode Brand Safety with Podchaser Pro

Ad Rate Card of The Lancet Diabetes & Endocrinology in conversation with

How much does it cost to advertise on The Lancet Diabetes & Endocrinology in conversation with?

PlacementCost
Pre-rollAds played before an episode.
Mid-rollAds played during an episode.
Post-rollAds played after an episode.

Frequently Asked Questions about The Lancet Diabetes & Endocrinology in conversation with

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features